{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T05:09:50Z","timestamp":1791090590105,"version":"4.1.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Cells, Molecules, and Diseases"],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1016\/j.bcmd.2011.02.005","type":"journal-article","created":{"date-parts":[[2011,4,9]],"date-time":"2011-04-09T04:59:49Z","timestamp":1302325189000},"page":"321-326","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["Identification of characteristic IGF2BP expression patterns in distinct B-ALL entities"],"prefix":"10.1016","volume":"46","author":[{"given":"Mindaugas","family":"Stoskus","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Egle","family":"Gineikiene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vilma","family":"Valceckiene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatrice","family":"Valatkaite","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Regina","family":"Pileckyte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laimonas","family":"Griskevicius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcmd.2011.02.005_bb0005","doi-asserted-by":"crossref","first-page":"5036","DOI":"10.1093\/nar\/26.22.5036","article-title":"The c-myc coding region determinant-binding protein: a member of a family of KH domain RNA-binding proteins","volume":"26","author":"Doyle","year":"1998","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.bcmd.2011.02.005_bb0010","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1128\/MCB.19.2.1262","article-title":"A family of insulin-like growth factor II mRNA-binding proteins represses translation in late development","volume":"19","author":"Nielsen","year":"1999","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bcmd.2011.02.005_bb0015","doi-asserted-by":"crossref","first-page":"29562","DOI":"10.1074\/jbc.M001156200","article-title":"H19 RNA binds four molecules of insulin-like growth factor II mRNA-binding protein","volume":"275","author":"Runge","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcmd.2011.02.005_bb0020","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1038\/nature04839","article-title":"CRD-BP mediates stabilization of betaTrCP1 and c-myc mRNA in response to beta-catenin signalling","volume":"441","author":"Noubissi","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.bcmd.2011.02.005_bb0025","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1038\/sj.emboj.7601039","article-title":"RNA-binding IMPs promote cell adhesion and invadopodia formation","volume":"25","author":"Vikesaa","year":"2006","journal-title":"EMBO J."},{"key":"10.1016\/j.bcmd.2011.02.005_bb0030","doi-asserted-by":"crossref","first-page":"4963","DOI":"10.1128\/MCB.00266-08","article-title":"Feedback regulation between zipcode binding protein 1 and beta-catenin mRNAs in breast cancer cells","volume":"28","author":"Gu","year":"2008","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bcmd.2011.02.005_bb0035","doi-asserted-by":"crossref","first-page":"8572","DOI":"10.1158\/0008-5472.CAN-09-1500","article-title":"Wnt signaling stimulates transcriptional outcome of the Hedgehog pathway by stabilizing GLI1 mRNA","volume":"69","author":"Noubissi","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.bcmd.2011.02.005_bb0040","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1074\/mcp.M600346-MCP200","article-title":"Molecular composition of IMP1 ribonucleoprotein granules","volume":"6","author":"Jonson","year":"2007","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.bcmd.2011.02.005_bb0045","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0925-4773(99)00160-4","article-title":"Expression of the highly conserved RNA binding protein KOC in embryogenesis","volume":"88","author":"Mueller-Pillasch","year":"1999","journal-title":"Mech. Dev."},{"key":"10.1016\/j.bcmd.2011.02.005_bb0050","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1084\/jem.189.7.1101","article-title":"A novel cytoplasmic protein with RNA-binding motifs is an autoantigen in human hepatocellular carcinoma","volume":"189","author":"Zhang","year":"1999","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bcmd.2011.02.005_bb0055","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1002\/ijc.1512","article-title":"C-MYC and IGF-II mRNA-binding protein (CRD-BP\/IMP-1) in benign and malignant mesenchymal tumors","volume":"94","author":"Ioannidis","year":"2001","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bcmd.2011.02.005_bb0060","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1038\/sj.bjc.6600806","article-title":"L523S, an RNA-binding protein as a potential therapeutic target for lung cancer","volume":"88","author":"Wang","year":"2003","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bcmd.2011.02.005_bb0065","first-page":"671","article-title":"Increased expression of IGF II mRNA-binding protein 1 mRNA is associated with an advanced clinical stage and poor prognosis in patients with ovarian cancer","volume":"24","author":"Gu","year":"2004","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.bcmd.2011.02.005_bb0070","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/S1470-2045(06)70732-X","article-title":"Analysis of RNA-binding protein IMP3 to predict metastasis and prognosis of renal-cell carcinoma: a retrospective study","volume":"7","author":"Jiang","year":"2006","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.bcmd.2011.02.005_bb0075","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1002\/ijc.22716","article-title":"Expression of oncofetal RNA-binding protein CRD-BP\/IMP1 predicts clinical outcome in colon cancer","volume":"121","author":"Dimitriadis","year":"2007","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bcmd.2011.02.005_bb0080","doi-asserted-by":"crossref","first-page":"7584","DOI":"10.1038\/sj.onc.1210563","article-title":"Expression of the RNA-binding protein IMP1 correlates with poor prognosis in ovarian carcinoma","volume":"26","author":"Kobel","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.bcmd.2011.02.005_bb0085","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/modpathol.3801016","article-title":"IMP-3 is a novel progression marker in malignant melanoma","volume":"21","author":"Pryor","year":"2008","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.bcmd.2011.02.005_bb0090","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1158\/1078-0432.CCR-07-2039","article-title":"IMP3 predicts aggressive superficial urothelial carcinoma of the bladder","volume":"14","author":"Sitnikova","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bcmd.2011.02.005_bb0095","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1002\/path.2376","article-title":"A role for VICKZ proteins in the progression of colorectal carcinomas: regulating lamellipodia formation","volume":"215","author":"Vainer","year":"2008","journal-title":"J. Pathol."},{"key":"10.1016\/j.bcmd.2011.02.005_bb0100","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1097\/PAS.0b013e3181483ff8","article-title":"The oncofetal protein IMP3: a novel biomarker for endometrial serous carcinoma","volume":"32","author":"Zheng","year":"2008","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.bcmd.2011.02.005_bb0105","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1097\/PAS.0b013e31818aada9","article-title":"An oncofetal protein IMP3: a new molecular marker for the detection of esophageal adenocarcinoma and high-grade dysplasia","volume":"33","author":"Lu","year":"2009","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.bcmd.2011.02.005_bb0110","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1038\/modpathol.2009.128","article-title":"Diagnostic utility of IMP3 in segregating metastatic melanoma from benign nevi in lymph nodes","volume":"22","author":"Mentrikoski","year":"2009","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.bcmd.2011.02.005_bb0115","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1016\/j.humpath.2009.05.005","article-title":"IMP3 is a novel biomarker for triple negative invasive mammary carcinoma associated with a more aggressive phenotype","volume":"40","author":"Walter","year":"2009","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.bcmd.2011.02.005_bb0120","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1016\/j.humpath.2009.05.003","article-title":"IMP-3 is differentially expressed in normal and neoplastic lymphoid tissue","volume":"40","author":"King","year":"2009","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.bcmd.2011.02.005_bb0125","doi-asserted-by":"crossref","first-page":"176","DOI":"10.3324\/haematol.10724","article-title":"Expression of the RNA-binding protein VICKZ in normal hematopoietic tissues and neoplasms","volume":"92","author":"Natkunam","year":"2007","journal-title":"Haematologica"},{"key":"10.1016\/j.bcmd.2011.02.005_bb0130","doi-asserted-by":"crossref","first-page":"19069","DOI":"10.1073\/pnas.0506637102","article-title":"Molecular signatures in childhood acute leukemia and their correlations to expression patterns in normal hematopoietic subpopulations","volume":"102","author":"Andersson","year":"2005","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"10.1016\/j.bcmd.2011.02.005_bb0135","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1038\/sj.leu.2404688","article-title":"Microarray-based classification of a consecutive series of 121 childhood acute leukemias: prediction of leukemic and genetic subtype as well as of minimal residual disease status","volume":"21","author":"Andersson","year":"2007","journal-title":"Leukemia"},{"key":"10.1016\/j.bcmd.2011.02.005_bb0140","doi-asserted-by":"crossref","first-page":"W577","DOI":"10.1093\/nar\/gki591","article-title":"DINAMelt web server for nucleic acid melting prediction","volume":"33","author":"Markham","year":"2005","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bcmd.2011.02.005_bb0145","first-page":"365","article-title":"Primer3 on the WWW for general users and for biologist programmers","volume":"132","author":"Rozen","year":"2000","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.bcmd.2011.02.005_bb0150","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1093\/nar\/17.7.2503","article-title":"Analysis of any point mutation in DNA. The amplification refractory mutation system (ARMS)","volume":"17","author":"Newton","year":"1989","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bcmd.2011.02.005_bb0155","doi-asserted-by":"crossref","first-page":"66","DOI":"10.2353\/jmoldx.2009.080039","article-title":"Single nucleotide polymorphism-based system improves the applicability of quantitative PCR for chimerism monitoring","volume":"11","author":"Gineikiene","year":"2009","journal-title":"J. Mol. Diagn."},{"key":"10.1016\/j.bcmd.2011.02.005_bb0160","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1038\/sj.leu.2403136","article-title":"Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using \u201creal-time\u201d quantitative reverse-transcriptase polymerase chain reaction (RQ\u2013PCR)\u2014a Europe Against Cancer program","volume":"17","author":"Beillard","year":"2003","journal-title":"Leukemia"},{"key":"10.1016\/j.bcmd.2011.02.005_bb0165","unstructured":"V. Valceckiene, R. Kontenyte, A. Jakubauskas, and L. Griskevicius, Selection of reference genes for quantitative polymerase chain reaction studies in purified B cells from B cell chronic lymphocytic leukaemia patients. Br. J. Haematol."},{"key":"10.1016\/j.bcmd.2011.02.005_bb0170","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1093\/nar\/29.9.e45","article-title":"A new mathematical model for relative quantification in real-time RT\u2013PCR","volume":"29","author":"Pfaffl","year":"2001","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bcmd.2011.02.005_bb0175","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1038\/sj.leu.2401592","article-title":"Standardized RT\u2013PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease. Report of the BIOMED-1 Concerted Action: investigation of minimal residual disease in acute leukemia","volume":"13","author":"van Dongen","year":"1999","journal-title":"Leukemia"},{"key":"10.1016\/j.bcmd.2011.02.005_bb0180","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1038\/sj.leu.2403135","article-title":"Standardization and quality control studies of \u201creal-time\u201d quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia\u2014a Europe Against Cancer program","volume":"17","author":"Gabert","year":"2003","journal-title":"Leukemia"},{"key":"10.1016\/j.bcmd.2011.02.005_bb0185","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.1182\/blood-2003-01-0338","article-title":"Classification of pediatric acute lymphoblastic leukemia by gene expression profiling","volume":"102","author":"Ross","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2011.02.005_bb0190","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S1535-6108(02)00032-6","article-title":"Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling","volume":"1","author":"Yeoh","year":"2002","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bcmd.2011.02.005_bb0195","doi-asserted-by":"crossref","first-page":"4645","DOI":"10.1182\/blood-2009-06-230037","article-title":"Identification of novel regulators of hematopoietic stem cell development through refinement of stem cell localization and expression profiling","volume":"114","author":"Mascarenhas","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2011.02.005_bb0200","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1182\/blood-2003-08-2955","article-title":"Insulin-like growth factor 2 expressed in a novel fetal liver cell population is a growth factor for hematopoietic stem cells","volume":"103","author":"Zhang","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2011.02.005_bb0205","doi-asserted-by":"crossref","first-page":"4297","DOI":"10.2741\/3006","article-title":"Grappling with the HOX network in hematopoiesis and leukemia","volume":"13","author":"McGonigle","year":"2008","journal-title":"Front. Biosci."},{"key":"10.1016\/j.bcmd.2011.02.005_bb0210","doi-asserted-by":"crossref","first-page":"3890","DOI":"10.1182\/blood-2003-10-3695","article-title":"TEL-AML1 promotes development of specific hematopoietic lineages consistent with preleukemic activity","volume":"103","author":"Morrow","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2011.02.005_bb0215","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1056\/NEJMra023001","article-title":"Acute lymphoblastic leukemia","volume":"350","author":"Pui","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bcmd.2011.02.005_bb0220","doi-asserted-by":"crossref","first-page":"20086","DOI":"10.1074\/jbc.M410036200","article-title":"CRD-BP\/IMP1 expression characterizes cord blood CD34+ stem cells and affects c-myc and IGF-II expression in MCF-7 cancer cells","volume":"280","author":"Ioannidis","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcmd.2011.02.005_bb0225","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/gcc.10199","article-title":"Prenatal origin of TEL-AML1-positive acute lymphoblastic leukemia in children born in California","volume":"37","author":"McHale","year":"2003","journal-title":"Genes Chromosom. Cancer"},{"key":"10.1016\/j.bcmd.2011.02.005_bb0230","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1016\/S0140-6736(99)09403-9","article-title":"Prenatal origin of acute lymphoblastic leukaemia in children","volume":"354","author":"Wiemels","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.bcmd.2011.02.005_bb0235","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1158\/0008-5472.CAN-03-2927","article-title":"Mammary tumor induction in transgenic mice expressing an RNA-binding protein","volume":"64","author":"Tessier","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.bcmd.2011.02.005_bb0240","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1038\/leu.2008.386","article-title":"Quantification of fusion transcript reveals a subgroup with distinct biological properties and predicts relapse in BCR\/ABL-positive ALL: implications for residual disease monitoring","volume":"23","author":"Zaliova","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.bcmd.2011.02.005_bb0245","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1677\/JME-09-0016","article-title":"IGF2 mRNA-binding protein 2: biological function and putative role in type 2 diabetes","volume":"43","author":"Christiansen","year":"2009","journal-title":"J. Mol. Endocrinol."}],"container-title":["Blood Cells, Molecules, and Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979611000337?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979611000337?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T12:27:27Z","timestamp":1761049647000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1079979611000337"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4]]},"references-count":49,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,4]]}},"alternative-id":["S1079979611000337"],"URL":"https:\/\/doi.org\/10.1016\/j.bcmd.2011.02.005","relation":{},"ISSN":["1079-9796"],"issn-type":[{"value":"1079-9796","type":"print"}],"subject":[],"published":{"date-parts":[[2011,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of characteristic IGF2BP expression patterns in distinct B-ALL entities","name":"articletitle","label":"Article Title"},{"value":"Blood Cells, Molecules, and Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcmd.2011.02.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}